Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CABA - Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market

CABA - Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market

Cabaletta Bio Inc.

2025-06-06 11:09:17 ET

Investment Overview

When I last covered Autolus Therapeutics plc ( AUTL ) for Seeking Alpha back in September last year, it was to make a Bull case for its shares, based on the UK-based biotech's upcoming PDUFA date for its autologous CAR-T cell therapy, obecabtagene autoleucel ("obe-cel"), in patients with relapsed/refractory (r/r) adult B-cell Acute Lymphoblastic Leukemia (B-ALL)....

For further details see:

Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market

Stock Information
Company Name: Cabaletta Bio Inc.
Stock Symbol: CABA
Market: NASDAQ
Website: cabalettabio.com
Menu
CABA CABA Quote CABA Short CABA News CABA Articles CABA Message Board
Get CABA Alerts

News, Short Squeeze, Breakout and More Instantly...